284 related articles for article (PubMed ID: 29093448)
1. Structure-mediated modulation of mRNA abundance by A-to-I editing.
Brümmer A; Yang Y; Chan TW; Xiao X
Nat Commun; 2017 Nov; 8(1):1255. PubMed ID: 29093448
[TBL] [Abstract][Full Text] [Related]
2. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.
Stellos K; Gatsiou A; Stamatelopoulos K; Perisic Matic L; John D; Lunella FF; Jaé N; Rossbach O; Amrhein C; Sigala F; Boon RA; Fürtig B; Manavski Y; You X; Uchida S; Keller T; Boeckel JN; Franco-Cereceda A; Maegdefessel L; Chen W; Schwalbe H; Bindereif A; Eriksson P; Hedin U; Zeiher AM; Dimmeler S
Nat Med; 2016 Oct; 22(10):1140-1150. PubMed ID: 27595325
[TBL] [Abstract][Full Text] [Related]
3. Regulation of RNA editing by RNA-binding proteins in human cells.
Quinones-Valdez G; Tran SS; Jun HI; Bahn JH; Yang EW; Zhan L; Brümmer A; Wei X; Van Nostrand EL; Pratt GA; Yeo GW; Graveley BR; Xiao X
Commun Biol; 2019; 2():19. PubMed ID: 30652130
[TBL] [Abstract][Full Text] [Related]
4. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
Yuting K; Ding D; Iizasa H
Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
[TBL] [Abstract][Full Text] [Related]
5. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
6. Using mouse models to unlock the secrets of non-synonymous RNA editing.
Jinnah H; Ulbricht RJ
Methods; 2019 Mar; 156():40-45. PubMed ID: 30827465
[TBL] [Abstract][Full Text] [Related]
7. Dynamic regulation of RNA editing in human brain development and disease.
Hwang T; Park CK; Leung AK; Gao Y; Hyde TM; Kleinman JE; Rajpurohit A; Tao R; Shin JH; Weinberger DR
Nat Neurosci; 2016 Aug; 19(8):1093-9. PubMed ID: 27348216
[TBL] [Abstract][Full Text] [Related]
8. Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR).
Solomon O; Oren S; Safran M; Deshet-Unger N; Akiva P; Jacob-Hirsch J; Cesarkas K; Kabesa R; Amariglio N; Unger R; Rechavi G; Eyal E
RNA; 2013 May; 19(5):591-604. PubMed ID: 23474544
[TBL] [Abstract][Full Text] [Related]
9. RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure.
Solomon O; Di Segni A; Cesarkas K; Porath HT; Marcu-Malina V; Mizrahi O; Stern-Ginossar N; Kol N; Farage-Barhom S; Glick-Saar E; Lerenthal Y; Levanon EY; Amariglio N; Unger R; Goldstein I; Eyal E; Rechavi G
Nat Commun; 2017 Nov; 8(1):1440. PubMed ID: 29129909
[TBL] [Abstract][Full Text] [Related]
10. Adenosine-to-inosine RNA editing.
Zinshteyn B; Nishikura K
Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
[TBL] [Abstract][Full Text] [Related]
11. ADAR-deficiency perturbs the global splicing landscape in mouse tissues.
Kapoor U; Licht K; Amman F; Jakobi T; Martin D; Dieterich C; Jantsch MF
Genome Res; 2020 Aug; 30(8):1107-1118. PubMed ID: 32727871
[TBL] [Abstract][Full Text] [Related]
12. irCLASH reveals RNA substrates recognized by human ADARs.
Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
[TBL] [Abstract][Full Text] [Related]
13. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
[TBL] [Abstract][Full Text] [Related]
14. RNA editing in cancer impacts mRNA abundance in immune response pathways.
Chan TW; Fu T; Bahn JH; Jun HI; Lee JH; Quinones-Valdez G; Cheng C; Xiao X
Genome Biol; 2020 Oct; 21(1):268. PubMed ID: 33106178
[TBL] [Abstract][Full Text] [Related]
15. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
16. All I's on the RADAR: role of ADAR in gene regulation.
Shevchenko G; Morris KV
FEBS Lett; 2018 Sep; 592(17):2860-2873. PubMed ID: 29770436
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs.
Vesely C; Tauber S; Sedlazeck FJ; von Haeseler A; Jantsch MF
Genome Res; 2012 Aug; 22(8):1468-76. PubMed ID: 22310477
[TBL] [Abstract][Full Text] [Related]
18. When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.
Wang Y; Liang H
Bioessays; 2018 Feb; 40(2):. PubMed ID: 29280160
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional effects of inosine modification in mRNA.
Mendoza HG; Beal PA
RNA; 2024 Apr; 30(5):512-520. PubMed ID: 38531652
[TBL] [Abstract][Full Text] [Related]
20. Inosine cyanoethylation identifies A-to-I RNA editing sites in the human transcriptome.
Sakurai M; Yano T; Kawabata H; Ueda H; Suzuki T
Nat Chem Biol; 2010 Oct; 6(10):733-40. PubMed ID: 20835228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
